Combination with BCG induction and maintenance therapy for high-risk non-muscle invasive bladder cancer. Meeks JJ, Powles T. Ann Oncol 2025 Oct 17:S0923-7534(25)04962-2. doi: 10.1016/j.annonc.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meeks JJ, Powles T. Combination with BCG induction and maintenance therapy for high-risk non-muscle invasive bladder cancer. Ann Oncol 2025 Oct 17:S0923-7534(25)04962-2. doi: 10.1016/j.annonc.2025.
PMID: 41110699